Treace Medical Concepts (TMCI) Net Margin (2020 - 2026)

Treace Medical Concepts has reported Net Margin for 7 years, with the latest figure at 38.64% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 810.0% year-over-year to 38.64%; the trailing twelve-month figure through Mar 2026 stood at 28.4% (down 309.0% YoY), and the FY2025 full-year result was 26.66%, up 12.0% from the prior year.
• Net Margin for Q1 2026 stood at 38.64%, down from 10.79% in the prior quarter.
• The five-year high for Net Margin was 0.9% in Q4 2024, with the low at 57.51% in Q2 2022.
• Historically, Net Margin has averaged 30.49% across 5 years, with a median of 32.62% in 2025.
• Annual changes were most pronounced in 2022 — Net Margin tumbled 3271 bps — and 2023, when it jumped 2803 bps.
• Treace Medical Concepts' Net Margin stood at 8.86% in 2022, then fell by 16 bps to 10.25% in 2023, then jumped by 91 bps to 0.9% in 2024, then plunged by 1098 bps to 10.79% in 2025, then tumbled by 258 bps to 38.64% in 2026.
• The last three Net Margin figures came in at 38.64% (Q1 2026), 10.79% (Q4 2025), and 32.62% (Q3 2025), per Business Quant data.